Nutriband Inc. Warrant (NTRBW)
Company News
Nutriband Announces Successful Meeting Completed With United States FDA For Its Abuse Deterrent Fentanyl Patch
Nutriband met with the FDA to discuss its AVERSAâ„¢ FENTANYL abuse deterrent patch, receiving guidance on regulatory pathway, manufacturing, and clinical study plans for a potential first-of-its-kind worldwide abuse deterrent fentanyl patch.
Nutriband Confirms Record and Pay date for 25% Preferred Stock Dividend as it Targets Filing for FDA Approval
Nutriband Inc. announced a 25% preferred stock dividend for shareholders, with record date on July 25th, 2025 and pay date on August 5th. The preferred shares are convertible to common stock upon FDA approval of their AVERSA Fentanyl product.